Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel murine model developed to test CNS-penetrant BTK inhibitors

Feb. 28, 2022

Bryostatin-1 promotes regenerative phenotype within microglia and CNS macrophages

Feb. 28, 2022

Targeting HNRNPA1 effective for treating multiple sclerosis-associated neurodegeneration

Feb. 25, 2022

Lung microbiome affects brain immune cells

Feb. 25, 2022

VK-1727 reduces EBV proliferation in cells from patients with multiple sclerosis

Feb. 25, 2022

LABP-66 shows promise for the treatment of multiple sclerosis

Feb. 25, 2022

GliaPharm and Wyss Center collaborate on new treatments for Alzheimer's disease

Feb. 24, 2022

EVs and their miRNAs released by inflammatory-primed stem cells may reverse brain inflammation

Feb. 24, 2022

Brain-derived extracellular vesicles participate in the prion-like propagation of tau in tauopathies

Feb. 24, 2022

ALPHA-1062 shown to be neuroprotective in rodent model of traumatic brain injury

Feb. 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...